Related Tags >> Amgen FDA Roche Phase III

Anemia drugs News

Most Popular Anemia drugs Story

Amgen layoffs: Good news for Ventura County?

September 10, 2007 — 10:14am ET | By Maureen Martino

Suffering from falling sales of its blockbuster anemia drugs, Amgen recently chopped its workforce as part of a widespread... Read more...

Anemia drugs Press Releases

Latest Headlines

PBMs making big bucks off specialty drugs
April 22, 2008
Troubled Amgen pays CEO $13.2M in compensation
April 2, 2008
Safety, efficacy problems sink Takeda drug
March 28, 2008
SPOTLIGHT: Amgen dodges a bullet
March 14, 2008
Amgen forecast darkens as FDA review looms
March 13, 2008
Experts to weigh in on Amgen's Nplate
March 12, 2008
GSK scraps malaria drug on anemia concerns
February 29, 2008
ALSO NOTED: Novartis faces development bottleneck; Bayer lowers 2008 expectations;and much more...
February 29, 2008
ALSO NOTED: Ardana looks to sale or merger; Oxigene inks $40M capital deal; and much more...
February 20, 2008
Amgen, Takeda ink massive development deals
February 4, 2008
ESA troubles sink Neose anemia drug program
January 30, 2008
Deal-making hits a faster pace in '07
December 21, 2007
Amgen reveals promising D-mab data
December 17, 2007
Denosumab: Amgen's salvation?
December 14, 2007
Amgen platelet therapy hits endpoint in Phase III
December 10, 2007
SPOTLIGHT: Researchers cure mice of sickle cell
December 7, 2007
Aranesp flunks late-stage trial for breast cancer
December 3, 2007
Mircera gets FDA nod, but blocked by patent case
November 15, 2007
The FDA: Caught between a rock and a hard place
November 9, 2007
ALSO NOTED: Merck settles 27,000 Vioxx suits; Amgen, J&J anemia drugs get stronger warnings; and much more...
November 9, 2007

Paid Research Reports